转子下内翻截骨术对兔Perthes病股骨头血管化及软骨内成骨的影响
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的
     儿童Perthes病经历了100多年的历史,仍然是一个疑难疾病,治疗的选择仍很困难。回顾大量文献发现转子下内翻截骨术对儿童Perthes病的治疗有很好的疗效,本研究通过建立兔Perthes病模型并探讨转子下内翻截骨术对兔Perthes病股骨头VEGF表达的影响,评价转子下内翻截骨术能否促进股骨头骺软骨的血管长入和软骨内成骨。
     方法
     2个月~2个半月龄新西兰大白兔34只,体重1.8~2.0kg。以每只兔右侧股骨头进行制作兔Perthes病模型,手术切断右侧圆韧带及股骨头支持带血供,建立兔Perthes病模型;造模2周后随机抽取2只兔处死,进行股骨头组织病理学观察证实造模成功。将32只兔随机分成A、B两组,A组16只兔,B组16只兔,B组行右侧股骨转子下内翻截骨术;于截骨术后2、4、6、8周每组分别随机抽取4只兔,行X线、腹主动脉造影、处死后肉眼观察双侧股骨头、病理组织学观察:(普通HE染色、VEGF免疫组织化学染色);将A、B两组兔左侧股骨头随机抽取16个作为空白组,B组右侧股骨头为实验组、A组右侧股骨头为对照组;所有数据均是运用SPSS17.0进行统计学分析的。
     结果
     兔perthes病模型制备成功,无1例死亡。
     大体观察:截骨术后各个时间点A、B两组兔左侧股骨头大体观察均处于兔perthes病股骨头大体观察分级的0级; A组兔右侧股骨头术后2周(1级水平2例、2级水平2例),术后4周(1级水平1例,2级水平1例、3级水平2例),术后6周(1级水平1例、3级水平3例),术后8周(2级水平2例、3级水平2例);术后2、4、6周B组兔右侧股骨头均(1级水平2例、2级水平2例),术后8周为(1级水平2例、2级水平1例、3级水平1例)。
     X线片观察:A、B两组左侧髋关节试验期间各个时间点均未发生明显变化,都处于兔perthes病X线分级的Ⅰ级水平。截骨术后2周A、B两组右侧股骨头分别有(Ⅰ级水平2例、Ⅱ级水平2例);术后4周A组右侧股骨头(Ⅱ级水平4例),术后6周(Ⅱ级水平2例、Ⅲ级水平2例),术后8周(Ⅱ级水平1例、Ⅲ级水平2例、Ⅳ级水平1例);术后4、6、8周B组兔右侧股骨头均处于Ⅱ级水平。动脉造影:X线摄片检查显示A组右侧股深浅动脉的分支较左侧未见明显的差别,B组右侧股深浅动脉的分支较左侧明显的增加,股骨近端手术区的血管数量明显增加。
     HE染色观察:造模后2周处死的2只兔右侧股骨头骺软骨内可见软骨陷窝,但软骨陷窝多空虚,骨髓腔由无定形的碎屑填充,骨小梁碎裂成片状或压缩成块,但无修复现象,证明造模成功。空白组股骨头各时间点未见股骨头坏死及骨修复现象。转子下内翻截骨术后2、4、6、8周各时间点A、B两组兔右侧股骨头坏死区的边缘可见新生血管的形成;并可见到新生的肉芽组织,侵入坏死区,吸收坏死骨;新生的肉芽组织由微血管、炎性细胞和成纤维细胞组成。但是B组兔在截骨术后第4周就出现了明显的骨修复,有新骨形成;对照组在第6周才出现明显的骨修复,新骨形成。免疫组织化学:空白组股骨头骺软骨的肥大区在各时间点均表现出较高的VEGF免疫反应性(VEGF immunoreactivity,VEGF-IR),但是其增殖区却表现较低;实验组和对照组的各个时间点股骨头骺软骨的肥大区的VEGF阳性细胞率比较有统计学意义(p<0.001),但在截骨术后2、4、6周的各个时间点均低于空白组,直到第8周才和空白组达到相当水平。空白组股骨头骺软骨增殖区各时间点VEGF阳性细胞率较低,远远低于实验组和对照组,实验组、对照组和空白组两两比较均有统计学意义(p<0.001);实验组的VEGF阳性细胞率高于对照组,数值并随时间延长而增加。
     结论
     1、VEGF在股骨头骺软骨坏死后促进其血管发生、骺软骨骨化中心的修复重建方面起着至关重要的调节作用。
     2、股骨转子下内翻截骨术可以促进截骨术区的血管长入。
     3、股骨转子下内翻截骨术可以增强VEGF的表达,从而促进坏死股骨头修复和缩短儿童Perthes病病程。
Objective
     Perthes’disease is still an enigmatic disease after it was described 100 years,and the ideal treatment of it is difficult to get.Lookaround reviews of the literature,the treatment of Perthes’disease with subtrochanteric varus osteotomy has good results.The aim of this study was to explore the change and their significance of VEGF expression in the femoral head after subtrochanteric varus osteotomy in a rabbit model,and to appraise wheather subtrochanteric varus osteotomy can promote new vascular invasion and cartilaginous ossification in the femoral head epiphysial cartilage.
     Materials and methods
     Thirty-four 2~2.5-month-old New Zealand rabbits were used(weighing 1.8~2.0Kg). A rabbit model of Perthes’disease was made by excision of right ligamentum teres and retinacular blood supplies of femoral head. At 2 weeks,2 rabbits were selected randomly, histological observations of the femoral head proved that the model of Perthes’disease was made successfully.Thirty-two New Zealand rabbits were divided into groups A and B randomly.Group B were operated with subtrochanteric varus osteotomy at 2 weeks after Perthes’disease model. 4 rabbites in each experimental goup were selected randomly and killed at 2,4,6,8 weeks.The gross appearance,X-ray film, abdominal aortography and histological observations (HE、VEGF) were carried out at 2,4,6,8 weeks after operation;16 left femoral heads were selected randomly from group A and B,which was the blank group,the right femoral heads of group A was the control group and the right femoral heads of group B was the test group. All the data were analyzed by the software SPSS 17.0.
     Results
     The rabbit model of Perthes’disease was made successfully;None of rabbits was dead.
     General observation:All the left femoral heads of group A and B were in grade 0 of the femoral head’s general observation grade at all time points after operation.The result of general observation of the right femoral heads of group A at two weeks after operation(2 cases in grade 1,2 cases in grade 2),at four weeks(1 case in grade 1,1 case in grade 2,2 cases in grade 3),at six weeks(1 case in grade1,3 cases in grade 3),at eight weeks(2 cases in grade 2,2 cases in grade 2); The result of general observation of the right femoral heads of group B at two,four,six weeks after operation(2 cases in grade 1,2 cases in grade 2),at eight weeks(2 cases in grade 1,1case in grade 2,1 case in grade 3).
     The results of X-ray: All the left femoral heads of group A and B were in gradeⅠof the femoral head’s X-ray grade,which were normal. The respective result of X-ray of the right femoral heads of group A and B at two weeks after operation(2 cases in gradeⅠ,2 cases in gradeⅡ); The result of X-ray of the right femoral heads of group A at four weeks after operation(4 cases in gradeⅡ),at six weeks(2 cases in gradeⅡ,2 cases in gradeⅢ),at eight weeks(1 case in gradeⅡ,2 cases in gradeⅢ,1 case in gradeⅣ); At four,six and eight weeks,all the right femoral heads of group B were in gradeⅡof the femoral head’s X-ray grade.
     Abdominal aortography data: Visually,There was no difference in both right superficial and profunda femoral arteries by radiographic examinations,and their branches of group A as compared with the left. There were increased number in both right superficial and profunda femoral arteries by radiographic examinations,and their branches of group B as compared with the left.There were increased vascularity in the region of the operated proximal femur.
     The HE staining observation:By 2 weeks,many empty lacunae were observed in the right femoral head epiphyseal cartilage of the 2 rabbits which were killed by two weeks after the induction of ischemia.The bone marrow cavity filled by the amorphous debris;Trabecular bone fragmented into a sheet or compressed into blocks,but the repair phenomenon was not observed.So,the rabbit model of Perthes’disease was made successfully.The femoral heads had no necrosis changes in blank group.At 2,4,6,8weeks after subtrochanteric varus osteotomy,neovascularization was observed at the periphery of the infarcted femoral head.Vascular granulation tissue was consisted of capillaries,inflammatory cells and fibroblastic cells. Vascular granulation tissue were seen invading the necrotic marrow space,and the resorption of dead bone.However,there were obviously bone reparation and new bone formation at 4 weeks after subtrochanteric varus osteotomy in group B;There were no bone reparation and new bone formation until the 6th weeks in group A.
     Immunohistochemistry staining:In the epiphyseal cartilage of the femoral heads of blank group,an intensive VEGF immunoreactivity(VEGF-IR) was found in the hypertrophic zone , and a low level of VEGF-IR in the proliferative zone at all time points.There were statistically significant differences in the ratios of VEGF+ cells in hypertrophic zone of the femoral heads between test group and control group at all time points(P<0.001),but the ratios of VEGF+ cells in hypertrophic zone of the femoral heads of test group and control group were significantly lower than blank group at 2,4,6 weeks,there were not reached a considerable level until the 8 weeks after subtrochanteric varus osteotomy of the three groups. The ratios of VEGF+ cells in the proliferative zone of the femoral heads of blank group were significantly lower than test group and control group at all time points.There were statistically significant differences in the ratios of VEGF+ cells in proliferative zone of the femoral heads between test group,control group and blank group by pairwise comparison at all time points(P<0.001). The ratios of VEGF+ cells of test group were significantly higher than blank group at all time points,which was increased with time.
     Conclusions
     1、It is obvious that VEGF act a key regulator that couples angiogenesis,cartilage remodeling,and ossification after ischemic damage to restore endochondral ossification in the epiphyseal cartilage.
     2、Subtrochanteric varus osteotomy can promote vascular invasion in the region of the operated proximal femur.
     3、Subtrochanteric varus osteotomy can promote VEGF upregulation and the repair of ischemic necrosis of the femoral head,and can shorten the course of Perthes’disease.
引文
[1] Wiig O,Terjesen T,Svenningsen S,Lie SA.The epidemiology and aetiology of Perthes’disease in Norway.A nationwide study of 425 patients[J].J Bone Joint Surg Br,2006,88(9):1217-1223.?
    [2] Henk E.Towards a better understanding of the aetiology of Legg-Calve-Perthes disease: acetabular retroversion may cause abnormal loading of dorsal femoral head-neck junction with restricted blood supply to the femoral epiphysis[J].J Med Hypotheses, 2007,68(5):995-997.?
    [3] Catterall A,Pringle J,Byers PD,et al.A review of the morphology of Perthes’disease[J].J Bone Joint Surg Br,1982,64(3):269-275.?
    [4] Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors[J].Nat Med, 2003,9(6):669–676?
    [5] Kim HK,Bian H,Randall T,et al.Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis[J].J Bone Miner Res,2004,19 (12)2014-2018.?
    [6]李伟,范清宇,马保安,等.兔Perthes病模型的建立及VEGF表达的试验研究[J].中国修复重建外科杂志,2008,7:814-819.?
    [7] Loder RT,Schwartz EM,Hensinger RN.Behavioral characteristics of children with legg- Calve-Perthes disease[J].J Pediatr Orthop,1993,13(5):598-601.
    [8] Atsumi T,Yamano K,Muraki M,Yoshihara S,Kajihara T.The blood supply of the lateral epiphyseal arteries in Perthes’disease[J].J Bone Joint Surg Br,2000,82(3):392-398.
    [9] Gallistl S,Reitinger T,Linhart W,Muntean W.The role of inherited thrombotic disorders in the etiology of Legg-Calve-Perthes disease[J].J Pediatr Orthop,1999,19(1):82-83.
    [10] Westhoff B,Krauspe R,Kalke AE, et al.Urinary excretion of deoxypyridinoline in Perthes’disease:a prospective,controlled comparative study in 83 children[J].J Bone Joint Surge Br,2006,88(7):967-971.
    [11] Gaughan DM,Mofenson LM,Hughes MD ,et al.Osteonecrosis of the hip (Legg -Calve–Perthes disease) in human immunodeficiency virus-infected children[J].J Pediatri- cs,2002,109(5):E74-4. ?
    [12] Miyamoto Y,Matsuda T,Kitoh H,et al.A recurrent mutation in typeⅡcollagen gene causes Legg-Calve-Perthes disease in a Japanese family[J].Hum Genet,2007,121 (5):625-629.
    [13] Su P,Li R,Liu S,et al.Age at onset-dependent presentations of premature hip osteo- arthritis,avascular necrosis of the femoral head,or Legg-Calve-Perthes disease in a single family,consequent upon a p.Gly1170Ser mutation of COL2A1[J].Arthritis Rheum,2008,58(6):1701-1706.
    [14] Martinez AG,Weinstein SL.Recurrent Legg-Calve-Perthes disease.Case report and review of the literature[J].J Bone Joint Surg Am,1991,73(7):1081-1085.
    [15] Carlson CS,Meuten DJ,Richardson DC.Ischemic necrosis of cartilage in spontaneous and experimental lesions of osteochondrosis[J].J Orthop Res,1991,9(3):317-329.
    [16] Kim HK,Su PH,Qiu YS.Histopathologic changes in growth-plate cartilage following ischemic necrosis of the capital femoral epiphysis.An experimental investigation in immature pigs[J].J Bone Joint Surg Am,2001,83-A(5):688-697.
    [17] Catterall A,Pringle J,Byers PD,et al.A review of the morphology of Perthes’dis- ease[J].J Bone Joint Surg Br,1982,64(3):269-275.
    [18] Jensen OM,Lauritzen J.Legg-Calve-Perthes disease.Morphological studies in two cas- es examined at necropsy[J].J Bone Joint Surg Br,1976,58(3):332-338.
    [19] Tachdjian MO,Grana L.Response of the hip joint to increased intra-articular hydros- tatic pressure[J].Clin Orthop Relat Res,1968,61:199-212.
    [20]闫宏伟,王坤正,时志斌,等.Legg-Perthes病动物模型实验研究[J].中国骨伤, 2002, 15(5):274-275.
    [21] Salter RB,Thompson GH.Legg-Calve-Perthes disease.The prognostic significance of the subchondral fracture and a two-group classification of the femoral head involvement[J].J Bone Joint Surg Am,1984,66(4):479-489.
    [22] Zahir A,Freeman AR.Cartilage changes following a single episode of infarction of the capital femoral epiphysis in the dog[J].J Bone Joint Surg Am,1972,54(1):125-136.
    [23] Zhang JF,Yang CJ,Wu T,et al.A two-degree-of-freedom hip exoskeleton device for an immature animal model of exercise-induced Legg-Calve-Perthes disease[J].Proc Inst Mech Eng H,2009,223(8):1059-1068.
    [24] Newton B,Crawford CJ,Powers DL,et al.The immature goat as an animal model for Legg-Calve-Perthes disease[J].J Invest Surg,1994,7(5):417-30.
    [25] Norman D,Reis D,Zmman C,et al.Vascular tepriration-induced necrosis of the femoral head of the rat.An experimental model of avascular osteonecrosis in the skeletally immture individual or Legg-Perthes disease[J].Int J Exp Pathol,1998,79(3):173-181.
    [26] Menezes NM,Connolly SA,Shapiro F,et al.Early ischemia in growing piglet skeleton: MR diffusion and perfusion imaging[J].Radiology,2007,242(1):129-136.
    [27]严军,董天华,董启榕,等.兔Perthes病模型的影像学研究[J].上海试验动物科学,20 02,22(1):13-15.
    [28]胥少汀,葛宝丰,徐印坎,等.实用骨科学[M].第二版,北京:人民军医出版社,2005, 1221-1230?
    [29] Wiig O,Terjesen T,Svenningsen S.Prognostic factors and outcome of treatment in Perthes’disease:a prospective study of 368 patients with five-year follow-up[J].J Bone Joint Surg Br,2008,90(10):1364-1371.
    [30]郭立民,赵刚,王积光,等.粗隆下截骨术治疗Legg-Calve-Perthes病108例分析[J].昆明医学院报,2006,27(3):91-93.?
    [31] Herceg MB,Cutright MT,Weiner DS.Remodeling of the proximal femur after upper f- emoral varus osteotomy for the treatment of Legg-Calve-Perthes disease[J].J Pediatr Orthop,2004,24(6):654-657.
    [32] Than P,Halmai V,Shaikh S,et al.Long-term results of derotational femoral varus osteotomy in Legg-Calve-Perthes disease:26-year follow-up[J]. Orthopedi cs,2003,26 (5):487-491.
    [33]符气祯,撩锦森,李佛保,等.儿童股骨头缺血性坏死疗效比较[J].中华骨科杂志,199 7,17(1):40-43.
    [34] Tischer E,Mitchell R,Hartman T,et al.The human gene for vascular endothelial growth factor.Multiple protein forms are encoded through alternative exon splicing[J].J Biol Chem,1991,266(18):11947-11954.
    [35]路璐,彭建军,胡大一.内皮祖细胞的血管再生作用[J].心血管病学进展,2004,25(5): 345-357.
    [36] Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secr- eted angiogenic mitogen[J].Science,1989,246(4935):1306-1309.
    [37] Plouet J,Schilling J,Gospodarowicz D.Isolation and characterization of a newly identi- fied endothelial cell mitogen produced by AtT-20 cells[J].EMBO J,1989,8 (12):3801- 3806.
    [38] Nagy JA,Vasile E,Feng D,Sundberg C,et al.Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis[J].J Exp Med,2002,196(11):1497-1506.
    [39] Compernolle V,Brusselmans K,Acker T,et al.Loss of HIF-2αand inhibition of VEGF impair fetal lung maturation,whereas treatment with VEGF prevents fatal respiratory distress in premature mice[J].Nat Med,2002,8(7):702-710.
    [40] Enomoto H,Inoki I,Komiya K,Shiomi T,Ikeda E,Shiomi T,Obata K,et al.Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage[J].Am J Pathol,2003,162(1):171-181.
    [41] Neufeld G,Cohen T,Gengrinovitch S,et al.Vascular endothelial growth factor(VEGF) and its receptors[J].FASEB J,1999,13(1):9-22.
    [42] Gerber HP,Dixit V,Ferrara N.Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells[J].J Biol Chem,1998,273(21):13313-13316.
    [43] Gerber HP,McMurtrey A,Kowalski J,et al.Vascular endothelial growth factor regula- tes endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal tran- sduction pathway.Requirement for Flk-1/KDR activation[J].J Biol Chem,1998,273 (46):30336-30343.
    [44] Benjamin LE,Golijanin D,Itin A,et al.Selective ablation of immature blood vessels in established human tumors follows vscular endothelial growth factor withdrawal[J].J Clin Invest,1999,103(2):159-165.
    [45] Yuan F,Chen Y,Dellian M,et al.Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an antivascular endothelial growth factor/vascular permeability factor antibody[J].Proc Natl Acad Sci U S A,1996,93(25):14765-14770.
    [46] Gerber HP,Hillan KJ,Ryan AM,et al.VEGF is required for growth and survival in neonatal mice[J].Development,1999,126(6):1149-1159.
    [47] Clauss M,Gerlach M,Gerlach H,et al.Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity,and promotes monocyte migration[J].J Exp Med,1990,172(6):1535-1545.
    [48] Broxmeyer HE,Cooper S,Li ZH,et al.Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor[J].Int J Hematol,1995,62(4):203-215.
    [49] Gabrilovich DI,Chen HL,Girgis KR,et al.Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells[J].Nat Med,1996,2(10):1096-1103.
    [50] Hattori K,Dias S,Heissig B,et al.Vascular endothelial growth factor and angiopoietin -1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoie- tic stem cells[J].J Exp Med,2001,193(9):1005-1014.
    [51] Gerber HP,Malik AK,Solar GP,et al.VEGF regulates haematopoietic stem cell survi- val by an internal autocrine loop mechanism[J].Nature,2002,417(6892):954-958.
    [52] Senger DR,Galli SJ,Dvorak AM,et al.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J].Science,1983,219 (4587): 983- 985.
    [53] Dvorak HF,Brown LF,Detmar M,et al.Vascular permeability factor/vascular endothel- ial growth factor,microvascular hyperpermeability,and angiogenesis[J].Am J Patho- l,1995,146(5):1029-1039.
    [54] Bates DO,Curry FE.Vascular endothelial growth factor increases microvascular perm- eability via a Ca(2+)-dependent pathway[J].Am J Physiol,1997,273(2 pt 2):H687-694.
    [55] Roberts WG,Palade GE.Increased microvascular permeability and endothelial fenest- ration induced by vascular endothelial growth factor[J].J Cell Sci, 1995, 108 (Pt6):2369-2379.
    [56] Getber HP,Vu TH,Ryan AM,et al.VEGF couples hypertrophic cartilage remodein- g,ossification and angiogenesis during endochondral bone formation[J].Nat Med,1999, 5(6):623-628.
    [57] Ryan AM,Eppler DB,Hagler KE,et al.Preclinical safety evaluation of rhuMAbV- EGF,an antiangiogenic humanized monoclonal antibody[J].Toxicol Pathol,1999, 27 (1):78-86.
    [58]于滕波,赵鹏,夏玉军,等.股骨颈骨折后股骨头局部VEGF的表达及意义[J].中国临床解剖学杂志,2004,22(5):546-548.
    [59]王垚,李琪佳,孙瑞军,等.VEGF及微血管密度在同种异体骨及自体骨移植修复兔桡骨缺损中的表达[J].中国修复重建外科杂志,2010,24(2):231-234.
    [60] Pufe T,Petersen W,Tillmann B,et al.The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage[J].Arthritis Rheum,2001,44(5):1082-1088.
    [61] Hashimoto S,Creighton-Achermann L.Takahashi K,et al.Development and regulation of osteophyte formation during experimental osteoarthritis[J].Osteoarthritis Cartilage,2002,10(3):180-187.
    [62] Lingaraj K,Poh CK,Wang W.Vascular endothelial growth factor(VEGF) is expressed during articular cartilage growth and re-expressed in osteoarthritis[J].Ann Acad Med Singapore,2010,39(5):399-403.
    [63] Yudoh K,Shi Y,Karasawa R.Angiogenic growth factors inhibit chondrocyte ageing in osteoarthritis:potential involvement of catabolic stress-induced overexpression of caveolin-1 in cellular ageing[J].Int J Rheum Dis,2009,12(2):90-99.
    [64]陈磊,王维山,王永明,等.膝关节镜下所见血管翳患者滑膜中VEGF、TGF-β1的表达及其意义[J].石河子大学学报,2010,28(1):72-75.
    [65] Shima DT,Gougos A,Miller JW,et al.Cloning and mRAN expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis[J].Invest Ophthalmol Vis Sci,1996,37(7):1334-1340.
    [66] Jingjing L,Srinivasan B,Bian X,et al.Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart[J].Mol Cell Biochem,2000,214(1-2):23-30.
    [67] Lamoke F,Labazi M,Montemari A,et al.Trans-Chalcone Prevents VEGF Expression and Retinal Neovascularization in the Ischemic Retina[J].Exp Eye Res,2011,[Epub ahead of print].
    [68] Horner A,Bishop NJ,Bord S,et al.Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage[J].J Anat,1999,194(Pt4):5 19-524.
    [1] Wiig O,Terjesen T,Svenningsen S,Lie SA.The epidemiology and aetiology of Pert- hes’disease in Norway.A nationwide study of 425 patients[J].J Bone Joint Surg Br,2006,88(9):1217-1223.
    [2] Henk E.Towards a better understanding of the aetiology of Legg-Calve-Perthes disease: acetabular retroversion may cause abnormal loading of dorsal femoral head-neckjunction with restricted blood supply to the femoral epiphysis[J].J Med Hypothes- es,2007,68(5):995-997.
    [3] Loder RT,Schwartz EM,Hensinger RN.Behavioral characteristics of children with Legg -Calve-Perthes disease[J].J Pediatr Orthop,1993,13(5):598-601.
    [4] Atsumi T,Yamano K,Muraki M,et al.The blood supply of the lateral epiphyseal arteries in Perthes’disease[J].J Bone Joint Surg Br,2000,82(3):392-398.
    [5] Gallistl S,Reitinger T,Linhart W,et al.The role of inherited thrombotic disorders in the etiology of Legg-Calve-Perthes disease[J].J Pediatr Orthop,1999,19(1):82-83.
    [6] Westhoff B,Krauspe R,Kalke AE,et al.Urinary excretion of deoxypyridinoline in Perthes’disease:a prospective,controlled comparative study in 83 children[J].J Bone Joint Surg Br,2006,88(7):967-971.
    [7] Miyamoto Y,Matsuda T,Kitoh H,et al.A recurrent mutation in typeⅡcollagen gene causes Legg-Calve-Perthes disease in a Japanese family[J].Hum Genet,2007,121(5): 625-629.
    [8] Su P,Li R,Liu S,et al.Age at onset-dependent presentations of premature hip osteoart- hritis,avascular necrosis of the femoral head,or Legg-Calve-Perthes disease in a single family,consequent upon a p.Gly1170Ser mutation of COL2A1[J].Arthritis Rheum,2008,58(6):1701-1706.
    [9] Catterall A,Pringle J,Byers PD,et al.A review of the morphology of Perthes’disease[J].J Bone Joint Surg Br,1982,64(3):269-275.
    [10] Catterall A.The natural history of Perthes’disease[J]. J Bone Joint Surg Br,1971,53(1): 37-53.
    [11] Nathan Sambandam S,Gul A,Shankar R,et al.Reliability of radiological classifications used in Legg-Calve-Perthes disease[J].J Pediatr Orthop B,2006,15(4):267-270.
    [12] Herring JA,Neustadt JB,Williams JJ,et al.The lateral pillar classification of Legg -Calve-Perthes disease[J].J Pediatr Orthop,1992,12(2):143-150.
    [13] Herring JA,Kim HT,Browne R.Legg-Calve-Perthes disease.Part I:Classification of radiographs with use of the modified lateral pillar and Stulberg classifications[J]. J Bone Joint Surg AM,2004,86-A(10):2103-2120.
    [14] Stulberg SD,Cooperman DR,Wallensten R.The natural history of Legg-Calve-Perthes disease[J].J Bone Joint Surg Am,1981,63(7):1095-1108.
    [15] Nelitz M,Lippacher S,Krauspe R,et al.Perthes’disease:current principles of diagnosis and treatment[J].Dtsch Arztebl Int,2009,106(31-32):517-523.
    [16] Wiig O,Terjesen T,Svenningsen S.Prognostic factors and outcome of treatment in Perthes’disease:a prospective study of 368 patients with five-year follow-up[J].J Bone Joint Surg Br.,2008,90(10):1364-1371.
    [17] Joseph B,Rao N,Mulpuri K,et al.How does a femoral varus osteotomy alter the natural evolution of Perthes’disease[J]? J Pediatr Orthop B,2005,14(1):10-15.
    [18] Kim HK.Legg-Calve-Perthes disease[J].J Am Acad Orthop Surg,2010,18(11): 676- 686.
    [19] Sharma S,Shewale S,Sibinski M,et al.Legg-Calve-Perthes disease affecting children less than eight years of age:a paired outcome study[J].Int Orthop,2009,33(1):231-235.
    [20] Wenger DR,Ward WT,Herring JA.Legg-Calve-Perthes disease[J].J Bone Joint Surg Am,1991,73(5):778-788.
    [21] Herring JA.The treatment of Legg-Calve-Perthes disease.A critical review of the literature[J].J Bone Joint Surg Am,1994,76(3):448-458.
    [22]卢毅,李士婉.高压氧治疗(且大文编译)[M].第一版,北京:人民军医出版社, 19 89,162-267.
    [23]吴生康,何鹤皋,陈海庭,等.高压氧治疗38例儿童股骨头缺血性坏死[J].中华航海医学与高气压医学杂志,2005,12(1):60-62.?
    [24]夏荣刚,陶海荣,吴生康.不负重高压氧治疗Perthes病[J].实用骨科杂志, 20 05,11(4):360-362.
    [25]邱建德,朱玉奎,李有才,等.介绍一种治疗儿童股骨头缺血性坏死的新方法[J].中华外科杂志,1981,19(1):14.
    [26]徐皓,马承宣,田家禾.髋关节滑膜切除对股骨头血液循环及关节软骨影响的动物试验[J].中华小儿外科杂志,1991,12:157-160.
    [27]符气祯,撩锦森,李佛保,等.儿童股骨头缺血性坏死疗效比较[J].中华骨科杂志, 19 97,17(1):40-43.
    [28]王西迅,诸葛天瑜,陈旭辉.血管束植入治疗儿童股骨头坏死的远期疗效分析.中国骨伤[J],2006,19(5):276-278.
    [29]吉士俊,马承宣,赫荣国,等.专题笔谈Perthes病[J].中华小儿科杂志,1994,15(3):183-185
    [30]吕洪海,薛克修,刘良庚,等.双带蒂骨瓣在儿童股骨头缺血性坏死的应用[J].中国矫形外科杂志,1999,6(12):933-934.
    [31]胥少汀,葛宝丰,徐印坎,等.实用骨科学[M].第二版,北京:人民军医出版社,2005, 1221-1230.
    [32] Herring JA,Kim HT,Browne R.Legg-Calve-Perthes disease.PartⅡ:Prospective mult- icenter study of the effect of treatment on outcome[J].J Bone Joint Surg Am,2004;86- A(10):2121-2134.
    [33]郭立民,赵刚,王积光,等.粗隆下截骨术治疗Legg-Calve-Perthes病108例分析[J].昆明医学院报,2006,27(3):91-93.
    [34] Herceg MB,Cutright MT,Weiner DS.Remodeling of the proximal femur after upper femoral varus osteotomy for the treatment of Legg-Calve-Perthes disease[J].J Pediatr Orthop,2004,24(6):654-657.
    [35] Kawasaki Y,Hanaoka N,Takahashi M,et al Percutaneous opening wedge varus osteot- omy with a multidrilling guide in Perthes’disease:a technical note on two cases[J].J Pediatr Orthop B,2009,18(5):242-247.
    [36] Salter RB.Role of innominate osteotomy in the treatment of congenital dislocation and subluxation of the hip in the older child[J].J Bone Joint Surg Am,1996,48(7): 14 13-1439.
    [37]赫荣国,梅海波.Salter骨盆截骨治疗Legg-Perthes病的远期结果观察[J].中国矫形外科杂志,2007,15(7):505-506,527.
    [38] Yoon TR,Rowe SM,Chung JY,et al.A new innominate osteotomy in Perthes’dise- ase[J].J Pediatr Orthop,2003,23(3):363-367.
    [39]许益文,李明,张德文,等.改良Salter三联截骨治疗儿童Perthes病[J].重庆医学,20 09,22(38):2860-2862.
    [40] Chiari K.Medial displacement osteotomy of the pelvis[J].Clin Orthop Relat Res,19 74, (98):55-71.
    [41]张志群,唐凯,潘新华,等.Chiari骨盆截骨术治疗Legg-Perthes病(附68例疗效分析) [J].伤残医学杂志,2005,13(1):39-40.
    [42]王西迅,孙捷,诸葛天瑜,等.改良Chiari骨盆截骨术结合展压塑形疗法治疗儿童股骨头坏死[J].中国矫形外科杂志,2005,13(15):1192-1193.
    [43] Daly K,Bruce C,Catterall A.Lateral shelf acetabuloplasty in Perthes’disease.A review of the end of growth[J].J Bone Joint Surg Br,1999,81(3):380-384.
    [44] Staheli LT,Chew DE.Slotted acetabular augmentation in childhood and adolescent- ce[J].J Pediatr Orthop,1992,12(5):569-580.
    [45]蔡海清,王志刚,杨根兴,等.槽状髋臼扩大术治疗儿童髋关节发育不良[J].中华小儿外科杂志,2005,26(2):83-86.
    [46] Walker KR,Nattrass GR,Graham HK.Slotted acetabular augmentation:is a hip spica necessary[J]? J Pediatr Orthop,2000,20(1):124-128.
    [47]张志群,唐凯,潘新华,等.Staheli槽式髋臼延伸术治疗儿童Perthes病[J].南京医科大学学报(自然科学版),2007,27(9):1020-1022.
    [48] Domzalski ME,Glutting J,Bowen JR,et al.Lateral acetabular growth srimulation following a labral support procedure in Legg-Calve-Perthes disease[J].J Bone Joint Surg Am,2006,88(7):1458-1466.
    [49] Willett K,Hudson I,Catterall A.Lateral shelf acetabuloplasty: an operation for older children with Perthes’disease[J].J Pediatr Orthop,1992,12(5):563-568.
    [50] Ghanem I,Haddad E,Haidar R,et al.Lateral shelf acetabuloplasty in the treatment of Legg-Calve-Perthes disease:improving mid-term outcome in severely deformed hips[J].J Child Orthop,2009,[Epub ahead of print].
    [51] Yoo WJ,Choi IH,Cho TJ,et al.Shelf acetabuloplasty for children with Perthes’disease and reducible subluxation of the hip: prognostic factors related to hip remodelling[J].J Bone Joint Surg Br,2009,91(10):1383-1387.
    [52] Bankes MJ,Catterall A,Hashemi-Nejad A.Valgus extension osteotomy for‘hinge abduction’in Perthes’disease.Results at maturity and factors influencing the radiological outcome[J].J Bone Joint Surg Br,2000,82(4):548-554.
    [53] Wenger DR,Kishan S,Pring ME.Impingement and childhood hip disease[J].J Pediatr Orthop B,2006,15(4):233-243.
    [54] Yoo WJ,Choi IH,Chung CY,et al.Valgus femoral osteotomy for hinge abduction in Perthes’disease.Decision-making and outcomes[J].J Bone Joint Surg Br, 2004, 86 (5): 726-730.
    [55] Wenger DR,Pring ME,Hosalkar HS,et al.Advanced containment methods for Legg -Calve-Perthes disease: results of triple pelvic osteotomy[J].J Pediatr Orthop,2010,3 0(8):749-757.
    [56]曲敬,巴智文,任思东,等.髋臼周围加股骨近端减压截骨术治疗儿童中晚期Perthes病[J].中国矫形外科杂志,2004,12(3,4):219-221.
    [57]任德胜,吴欣乐,易申德,等.组合式手术治疗儿童Perthes病[J].中国矫形外科杂志,2008,16(21):1605-1608.
    [58]孙克民,林乔龄,郑亚明,等.成骨通络丸治疗儿童股骨头缺血性坏死22例[J].福建中医学院学报,2004,14(3):26-28.
    [59]袁普卫,张军,周海哲.中西医结合治疗早期Legg-Calve-Perthes征的临床研究[J].陕西中医学院学报,2004,27(6):58-59.
    [60]孙捷,诸葛天瑜,李恩典,等.活骨胶囊治疗儿童股骨头坏死52髋报告[J].中国中医骨伤科杂志,2005,13(6):45-46.
    [61] Anderson LA, Erickson JA, Severson EP.et alSequelae of Perthes’disease: treatment with surgical hip dislocation and relative femoral neck lengthening[J].J Pediatr Orthop,2010,30(8):7587-66.
    [62]陈小刚,张雪非.自体骨髓移植治疗儿童股骨头缺血性坏死[J].现代医学,2010,38 (1):57-59.
    [63]宁锦龙,黄剑峰.股骨头表面重建术治疗Ⅳ期Perthes病的疗效观察[J].中国伤残医学,2008,16(5):6-7.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700